Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tocilizumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03895879
What this trial is testing

Use of Tocilizumab Drug Levels to Optimize Treatment in RA

Who this might be right for
Rheumatoid Arthritis
Reade Rheumatology Research Institute 98
Early research (Phase 1)Study completedNCT02678988
What this trial is testing

Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 189
Early research (Phase 1)Study completedNCT04885829
What this trial is testing

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

Who this might be right for
Rheumatoid ArthritisGiant Cell Arteritis
Syneos Health 300
Early research (Phase 1)Study completedNCT06262477
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants

Who this might be right for
Healthy Volunteer
Biogen 300
Post-approval studies (Phase 4)Ended earlyNCT02659150
What this trial is testing

Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Massachusetts General Hospital 16
Testing effectiveness (Phase 2)UnknownNCT04315480
What this trial is testing

Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis

Who this might be right for
SARS Pneumonia
Università Politecnica delle Marche 38
Large-scale testing (Phase 3)Study completedNCT01347983
What this trial is testing

Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Chugai Pharma Taiwan 72
Not applicableLooking for participantsNCT07801638
What this trial is testing

Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
Capital Medical University 80
Early research (Phase 1)Ended earlyNCT02336048
What this trial is testing

A Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Comorbidities

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Hoffmann-La Roche 38
Large-scale testing (Phase 3)Study completedNCT02908217
What this trial is testing

Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

Who this might be right for
Polymyalgia Rheumatica
University Hospital, Brest 113
Testing effectiveness (Phase 2)Study completedNCT02206035
What this trial is testing

Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
William R. Drobyski, MD 45
Testing effectiveness (Phase 2)Study completedNCT04339712
What this trial is testing

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction

Who this might be right for
COVID-19Virus DiseasesMacrophage Activation Syndrome+1 more
Hellenic Institute for the Study of Sepsis 102
Large-scale testing (Phase 3)Active Not RecruitingNCT03892785
What this trial is testing

MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial

Who this might be right for
Giant Cell Arteritis
Centre Hospitalier Universitaire Dijon 230
Testing effectiveness (Phase 2)Study completedNCT01396317
What this trial is testing

Study of Tocilizumab to Treat Polymyalgia Rheumatica

Who this might be right for
Polymyalgia Rheumatica (PMR)
Hospital for Special Surgery, New York 10
Not applicableStudy completedNCT02251860
What this trial is testing

Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,454
Not applicableStudy completedNCT04690920
What this trial is testing

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Who this might be right for
Corona Virus Disease 2019 (COVID-19)
University of Lahore 200
Large-scale testing (Phase 3)Study completedNCT03202368
What this trial is testing

An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)

Who this might be right for
Giant Cell Arteritis
Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Temporarily pausedNCT03787290
What this trial is testing

Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 35
Not applicableStudy completedNCT01633346
What this trial is testing

Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 50
Early research (Phase 1)Study completedNCT02906371
What this trial is testing

Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome

Who this might be right for
Lymphoblastic Leukemia, Acute, Childhood
University of Pennsylvania 80
Next Page